Our Latest Investment: LabCycle

We’re delighted to announce that our latest investment, and the second deployment from our EIS fund, is in LabCycle, founded by Helen Liang (CTO) and Colin Francis (CEO). LabCycle pioneers the circular economy of contaminated laboratory plastics using their patented AutoDecon technology, turning waste into a high-quality resource. We're also excited that LabCycle are the second investment from our EIS Fund.

Chris Connelly, who led the due diligence team for Angel Academe says: "We are delighted to have the opportunity to invest in Labcyle. Research and healthcare organisations generate vast volumes of contaminated waste that only Labcycle can recycle, reducing both carbon emissions and cost.".

Helen Liang says: "“It’s been hugely encouraging to work with investors who bring genuine conviction, thoughtful challenge and strong support for founders. Angel Academe and Syndicate Room have backed both the urgency of the problem and the strength of our team, and we’re excited to have them alongside us as we scale LabCycle and transform how research and healthcare industries handle plastic waste.”".

Tom Britton, Partner at Syndicate Room commented: "Plastic waste from bio and clinical labs accounts for nearly 1.5% of total global plastic waste. Until now, there simply hasn't been the technology or the logistical framework to handle it, leading to a massive structural waste of high-value materials. Backing LabCycle is a clear-cut decision for us; it aligns significant economic potential with a profound environmental impact. They aren't just recycling; they are solving a multi-billion pound logistics and sustainability problem for the entire life sciences industry."